Comet (COTN) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
2 Feb, 2026Executive summary
Net sales for H1 2024 were CHF 189.3 million, down 8.6% year-over-year, with a weak Q1 followed by a Q2 recovery driven by the semiconductor cycle turnaround.
Semiconductor market recovery led to a 22% year-over-year increase in incoming orders and a book-to-bill ratio of 1.1, up from 0.8 in H1 2023.
Free cash flow improved from -CHF 15.3 million to +CHF 8.1 million, supported by lower working capital and CapEx.
Net income rose to CHF 4.1 million, up 109.6% year-over-year, driven by improved financial results and lower costs.
All divisions are on track for H2 growth, with PCT benefiting from semiconductor recovery, IXS focusing on advanced packaging, and IXM positioned for batteries and electronics.
Financial highlights
Net sales: CHF 189.3 million (-8.6% year-over-year); EBITDA: CHF 13.0 million (-9.1%); EBITDA margin: 6.9% (stable year-over-year); net income: CHF 4.1 million (+109.6%).
Gross profit margin improved to 40.1% (+0.9pp year-over-year), aided by cost controls and lower idle costs.
Free cash flow: CHF 8.1 million (H1 2023: CHF -15.3 million); capex as % of sales: 2.5% (down from 9.4%).
Cash and cash equivalents: CHF 84.6 million; net debt: CHF 12.4 million; equity ratio: 61.9%.
Earnings per share: CHF 0.52 (up 108% year-over-year).
Outlook and guidance
Full-year 2024 guidance confirmed: net sales expected between CHF 440–480 million, EBITDA margin 15–17%.
Semiconductor equipment industry forecasted to grow 3–5% in 2024, accelerating to 14% in 2025.
Anticipates further increase in incoming orders and sales in H2, with high backlog and operational readiness.
Expects a significantly better result for FY 2024 than the previous year.
CapEx expected to accelerate in H2 but end below initial guidance.
Latest events from Comet
- Sales up 2.6% with strong 2026 outlook as semiconductor demand and margins set to rise.COTN
H2 20256 Mar 2026 - Double-digit growth and margin expansion driven by semiconductor recovery and PCT strength.COTN
H2 202417 Dec 2025 - Strong sales growth led by PCT, but margin pressure and cautious FY25 outlook persist.COTN
H1 202516 Nov 2025 - RF and x-ray innovation, AI, and Asian expansion target CHF 670–770M sales by 2028.COTN
CMD 202513 Nov 2025 - Q3 sales fell 9.4% year-over-year, but full-year guidance remains, with recovery seen in 2026.COTN
Q3 2025 TU17 Oct 2025